CynergisTek Will Host Conference Call On Monday, May 16, 2022, To Discuss First-Quarter 2022 Financial Results

May 13, 2022 CynergisTek, Inc.

Austin, TX (May 11, 2022) – CynergisTek (NYSE AMERICAN: CTEK), leading cybersecurity, privacy, compliance, and IT audit firm helping organizations in highly regulated industries navigate emerging security and privacy issues, today announced that management will host a conference call at 4:30 PM Eastern Time on Monday, May 16, 2022, to discuss first-quarter 2022 financial results. The results will be released prior to the call. 

Date: Monday, May 16, 2022 
Time: 4:30 pm ET / 1:30 pm PT 
U.S.: 1-888-394-8218 
International: 1-786-789-4776 
Conference ID: 8001259 
Webcast:  https://event.choruscall.com/mediaframe/webcast.html?webcastid=W6CXE7Cj

A replay of the call will be available from 7:30 PM ET on May 16, 2022 to 11:59 PM ET on May 23, 2022. To access the replay, please dial 1-844-512-2921 from the U.S. and 1-412-317-6671 from outside the U.S. The PIN is 8001259.  

About CynergisTek, Inc.  

CynergisTek is a top-ranked cybersecurity consulting firm helping organizations in highly-regulated industries, including those in healthcare, government, and finance navigate emerging security and privacy issues. CynergisTek combines intelligence, expertise, and a distinct methodology to validate a company's security posture and ensure the team is rehearsed, prepared, and resilient against threats. Since 2004, CynergisTek has been dedicated to hiring and retaining experts who bring real-life experience and hold advanced certifications to support and educate the industry by contributing to relevant industry associations. For more information, visit www.cynergistek.com or follow us on Twitter or LinkedIn.  

Cautionary Note Regarding Forward Looking Statements  

This release contains certain forward-looking statements relating to the business of CynergisTek.  These forward-looking statements are within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and can be identified by the use of forward-looking terminology such as “believes,” “expects,” “anticipates,” “would,” “could,” “intends,” “may,” “will,” or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including but not limited to uncertainties relating to product/services development; long and uncertain sales cycles; the ability to obtain or maintain proprietary intellectual property protection; future capital requirements; competition from other providers; the ability of the Company’s vendors to continue supplying the Company with supplies and services at comparable terms and prices; the Company’s ability to successfully compete and introduce enhancements and new features that achieve market acceptance and that keep pace with technological developments; the Company’s ability to maintain its brand and reputation and retain or replace its significant customers; cybersecurity risks and risks of damage and interruptions of information technology systems; the Company’s ability to retain key members of management and successfully integrate new executives; the Company’s ability to complete acquisitions, strategic investments, entry into new lines of business, divestitures, mergers or other transactions on acceptable terms, or at all; potential risks and uncertainties relating to the existing and ultimate impact of the COVID-19 pandemic, including actions that may be taken by governmental authorities to contain the COVID-19 outbreak or to treat its impact, and the potential negative impacts of COVID-19 on the global economy and financial markets; the general economic impact of the ongoing war in Ukraine, including the impact of related sanctions being imposed by the U.S. Government and the governments of other countries, and the impact of potential reprisals as a consequence of the war in Ukraine and any related sanctions; and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected.   Certain of these risks and uncertainties are or will be described in greater detail in the Company’s Form 10-K and Form 10-Q filings with the Securities and Exchange Commission, which are available at http://www.sec.gov.  Given the risks and uncertainties, readers should not place undue reliance on any forward-looking statement and should recognize that the statements are predictions of future results which may not occur as anticipated. Many of the risks listed above have been, and may further be, exacerbated by the COVID-19 pandemic, including its impact on the healthcare industry, or the ongoing war in Ukraine. Actual results could differ materially from those anticipated in the forward-looking statements and from historical results, due to the risks and uncertainties described herein, as well as others not now anticipated. CynergisTek is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.  

###       

CynergisTek Investor Relations Contact:   

CynergisTek, Inc.       
Bryan Flynn       
(512) 402-8550 x7       
InvestorRelations@cynergistek.com         

CynergisTek Media Contact:   

CynergisTek, Inc.      
Trinity McPherson    
(443) 853-8468      
trinity.mcpherson@cynergistek.com 

 

About the Author

CynergisTek, Inc.

CynergisTek is a top-ranked cybersecurity consulting firm dedicated to serving the information assurance needs of healthcare. CynergisTek offers specialized services and solutions to help organizations achieve privacy, security, and compliance goals. The company has been recognized by KLAS in the 2016 and 2018 Cybersecurity reports as a top performing firm in healthcare cybersecurity, as well as the 2017 Best in KLAS winner for Cybersecurity Advisory Services.

Follow on Twitter Follow on Linkedin Visit Website More Content by CynergisTek, Inc.
Previous Article
CynergisTek Files First Quarter 2022 Financial Results
CynergisTek Files First Quarter 2022 Financial Results

CynergisTek Files First Quarter 2022 Financial Results and announces financial results for the three months...

Next Article
CynergisTek Adds New West Coast Health Care Agency to Growing Client Base for Information Blocking and Interoperability Services
CynergisTek Adds New West Coast Health Care Agency to Growing Client Base for Information Blocking and Interoperability Services

New client turns to CynergisTek for compliance expertise and information blocking and interoperability serv...